

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.32174729 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.44056309 |
| 3 | response to muramyl dipeptide (GO:0032495) | 4.41783461 |
| 4 | cellular extravasation (GO:0045123) | 4.32580205 |
| 5 | response to peptidoglycan (GO:0032494) | 4.19046366 |
| 6 | histone H4 deacetylation (GO:0070933) | 3.97649642 |
| 7 | NIK/NF-kappaB signaling (GO:0038061) | 3.76606793 |
| 8 | germinal center formation (GO:0002467) | 3.67572944 |
| 9 | positive regulation of granulocyte differentiation (GO:0030854) | 3.63190243 |
| 10 | mannose metabolic process (GO:0006013) | 3.60032314 |
| 11 | T cell migration (GO:0072678) | 3.57483917 |
| 12 | histone H3-K36 demethylation (GO:0070544) | 3.52658963 |
| 13 | regulation of histone H3-K27 methylation (GO:0061085) | 3.46926818 |
| 14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.40168801 |
| 15 | histone H3 deacetylation (GO:0070932) | 3.39312051 |
| 16 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.39059665 |
| 17 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.38778835 |
| 18 | positive regulation of B cell differentiation (GO:0045579) | 3.31803468 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.29037759 |
| 20 | regulation of chemokine biosynthetic process (GO:0045073) | 3.28690564 |
| 21 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.26166503 |
| 22 | histone H3-K4 methylation (GO:0051568) | 3.22057771 |
| 23 | B cell receptor signaling pathway (GO:0050853) | 3.20957319 |
| 24 | regulation of granulocyte differentiation (GO:0030852) | 3.20693659 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16760925 |
| 26 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.15861517 |
| 27 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.11832408 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.10576631 |
| 29 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.01687170 |
| 30 | negative thymic T cell selection (GO:0045060) | 3.01566187 |
| 31 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.98655490 |
| 32 | histone lysine demethylation (GO:0070076) | 2.95978250 |
| 33 | regulation of mast cell degranulation (GO:0043304) | 2.95318945 |
| 34 | histone H3-K4 trimethylation (GO:0080182) | 2.94820823 |
| 35 | T cell selection (GO:0045058) | 2.87504950 |
| 36 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.87234065 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 2.85671341 |
| 38 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.85201728 |
| 39 | dosage compensation (GO:0007549) | 2.84396553 |
| 40 | positive T cell selection (GO:0043368) | 2.84324566 |
| 41 | histone demethylation (GO:0016577) | 2.83840245 |
| 42 | negative regulation of granulocyte differentiation (GO:0030853) | 2.79871667 |
| 43 | thymic T cell selection (GO:0045061) | 2.79021510 |
| 44 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.78738493 |
| 45 | regulation of chromatin binding (GO:0035561) | 2.77264895 |
| 46 | regulation of leukocyte degranulation (GO:0043300) | 2.76994806 |
| 47 | negative regulation of phagocytosis (GO:0050765) | 2.76751919 |
| 48 | negative regulation of interleukin-8 production (GO:0032717) | 2.75537216 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.74259590 |
| 50 | negative regulation of cell killing (GO:0031342) | 2.74259590 |
| 51 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.74201534 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 2.74036126 |
| 53 | response to protozoan (GO:0001562) | 2.73487074 |
| 54 | protein-DNA complex disassembly (GO:0032986) | 2.72755245 |
| 55 | nucleosome disassembly (GO:0006337) | 2.72755245 |
| 56 | regulation of ARF GTPase activity (GO:0032312) | 2.72733462 |
| 57 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.72644145 |
| 58 | Peyers patch development (GO:0048541) | 2.72644145 |
| 59 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.72184015 |
| 60 | immunoglobulin mediated immune response (GO:0016064) | 2.70456690 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70362778 |
| 62 | response to laminar fluid shear stress (GO:0034616) | 2.70081681 |
| 63 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.69027099 |
| 64 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.69009724 |
| 65 | negative T cell selection (GO:0043383) | 2.67573380 |
| 66 | megakaryocyte development (GO:0035855) | 2.64327252 |
| 67 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.63717730 |
| 68 | defense response to protozoan (GO:0042832) | 2.62069797 |
| 69 | V(D)J recombination (GO:0033151) | 2.61815623 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60509740 |
| 71 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.60411417 |
| 72 | histone H3-K9 demethylation (GO:0033169) | 2.59082110 |
| 73 | neutrophil activation involved in immune response (GO:0002283) | 2.58967035 |
| 74 | positive regulation of myotube differentiation (GO:0010831) | 2.58786815 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.58649488 |
| 76 | cellular response to ethanol (GO:0071361) | 2.57804780 |
| 77 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.56991360 |
| 78 | neutrophil mediated immunity (GO:0002446) | 2.54914439 |
| 79 | protein demethylation (GO:0006482) | 2.54653721 |
| 80 | protein dealkylation (GO:0008214) | 2.54653721 |
| 81 | spermatid nucleus differentiation (GO:0007289) | 2.54537132 |
| 82 | positive regulation by symbiont of host defense response (GO:0052509) | 2.54079054 |
| 83 | modulation by symbiont of host defense response (GO:0052031) | 2.54079054 |
| 84 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.54079054 |
| 85 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.54079054 |
| 86 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.54079054 |
| 87 | modulation by symbiont of host immune response (GO:0052553) | 2.54079054 |
| 88 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.54026644 |
| 89 | B cell homeostasis (GO:0001782) | 2.52511017 |
| 90 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.51462587 |
| 91 | regulation of erythrocyte differentiation (GO:0045646) | 2.51154046 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.48972413 |
| 93 | myeloid cell activation involved in immune response (GO:0002275) | 2.47793385 |
| 94 | regulation of monocyte differentiation (GO:0045655) | 2.46647015 |
| 95 | histone deacetylation (GO:0016575) | 2.46309613 |
| 96 | natural killer cell differentiation (GO:0001779) | 2.43966023 |
| 97 | negative regulation of growth of symbiont in host (GO:0044130) | 2.42510673 |
| 98 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.42510673 |
| 99 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.42510673 |
| 100 | regulation of growth of symbiont in host (GO:0044126) | 2.42510673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.92558105 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.68885176 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.97697100 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.73906314 |
| 5 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.71299080 |
| 6 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.57285803 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.53383613 |
| 8 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.52972203 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.50709203 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47411865 |
| 11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.44354767 |
| 12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.40986774 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.38159695 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27533224 |
| 15 | MAF_26560356_Chip-Seq_TH2_Human | 2.24000878 |
| 16 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.22979209 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.22039007 |
| 18 | UTX_26944678_Chip-Seq_JUKART_Human | 2.21173741 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.19449375 |
| 20 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.16312077 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08782115 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00519536 |
| 23 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98804989 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95429929 |
| 25 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.94969660 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93108270 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.91817157 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91512844 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.83495035 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82443166 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.79023556 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75773042 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72093172 |
| 34 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.70293448 |
| 35 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.70071697 |
| 36 | P68_20966046_ChIP-Seq_HELA_Human | 1.69954615 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.66266879 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.64756291 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61283085 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60390809 |
| 41 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.59640291 |
| 42 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.58106588 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.57432086 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.56543442 |
| 45 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.56345797 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55600489 |
| 47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.55514996 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50370001 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.48593749 |
| 50 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.48364855 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47027773 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46104821 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40735787 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37276560 |
| 55 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36880854 |
| 56 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36527629 |
| 57 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36523004 |
| 58 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35878961 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34850331 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34319409 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34015948 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33813468 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33194763 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33083603 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30967269 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.30270423 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29048608 |
| 68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.28211599 |
| 69 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.27046403 |
| 70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25982683 |
| 71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25975247 |
| 72 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23670964 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22659892 |
| 74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21369222 |
| 75 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.19190068 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18831240 |
| 77 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.18455223 |
| 78 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16903605 |
| 79 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14392922 |
| 80 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13990744 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13542860 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11587877 |
| 83 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10953747 |
| 84 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10888898 |
| 85 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10427555 |
| 86 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09100154 |
| 87 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.08125232 |
| 88 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07805441 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07734062 |
| 90 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07507866 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06819844 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05712022 |
| 93 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05691690 |
| 94 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.03169047 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.02786639 |
| 96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99559849 |
| 97 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99440737 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98687948 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97337063 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96275615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009278_abnormal_bone_marrow | 3.76930200 |
| 2 | MP0003436_decreased_susceptibility_to | 3.76532551 |
| 3 | MP0005451_abnormal_body_composition | 3.65519480 |
| 4 | MP0003303_peritoneal_inflammation | 3.39939514 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.38026855 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.04933670 |
| 7 | MP0005397_hematopoietic_system_phenotyp | 2.93425934 |
| 8 | MP0001545_abnormal_hematopoietic_system | 2.93425934 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.52823333 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.33465555 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.32427085 |
| 12 | MP0002419_abnormal_innate_immunity | 2.31011466 |
| 13 | MP0001800_abnormal_humoral_immune | 2.30167301 |
| 14 | MP0005387_immune_system_phenotype | 2.19206789 |
| 15 | MP0001790_abnormal_immune_system | 2.19206789 |
| 16 | MP0005671_abnormal_response_to | 2.15747431 |
| 17 | MP0005025_abnormal_response_to | 2.14380615 |
| 18 | MP0002723_abnormal_immune_serum | 2.04437953 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.00140272 |
| 20 | MP0002420_abnormal_adaptive_immunity | 1.99275988 |
| 21 | MP0001819_abnormal_immune_cell | 1.96931353 |
| 22 | MP0002398_abnormal_bone_marrow | 1.95038278 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.93927556 |
| 24 | MP0009785_altered_susceptibility_to | 1.92199569 |
| 25 | MP0004947_skin_inflammation | 1.91426282 |
| 26 | MP0000685_abnormal_immune_system | 1.90076572 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.88010510 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.83923708 |
| 29 | MP0001853_heart_inflammation | 1.83580139 |
| 30 | MP0004510_myositis | 1.80635802 |
| 31 | MP0001873_stomach_inflammation | 1.73446899 |
| 32 | MP0005410_abnormal_fertilization | 1.71931514 |
| 33 | MP0000716_abnormal_immune_system | 1.70859882 |
| 34 | MP0009840_abnormal_foam_cell | 1.68539663 |
| 35 | MP0002722_abnormal_immune_system | 1.68501947 |
| 36 | MP0002405_respiratory_system_inflammati | 1.64627315 |
| 37 | MP0003221_abnormal_cardiomyocyte_apopto | 1.61602556 |
| 38 | MP0000703_abnormal_thymus_morphology | 1.57867120 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.56470714 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.56063749 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.53590442 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.52679681 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.52450042 |
| 44 | MP0003091_abnormal_cell_migration | 1.47588645 |
| 45 | MP0002429_abnormal_blood_cell | 1.47565801 |
| 46 | MP0006082_CNS_inflammation | 1.44364206 |
| 47 | MP0002132_abnormal_respiratory_system | 1.39502068 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.39201644 |
| 49 | MP0008995_early_reproductive_senescence | 1.37728346 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.32120865 |
| 51 | MP0010155_abnormal_intestine_physiology | 1.29700581 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.29094195 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.22302310 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.20768925 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.19394112 |
| 56 | MP0008260_abnormal_autophagy | 1.19035336 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 1.17238872 |
| 58 | MP0000858_altered_metastatic_potential | 1.16374023 |
| 59 | MP0008057_abnormal_DNA_replication | 1.13837720 |
| 60 | MP0002933_joint_inflammation | 1.11350851 |
| 61 | MP0008469_abnormal_protein_level | 1.09876220 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.07909049 |
| 63 | MP0004233_abnormal_muscle_weight | 1.06525029 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.06481000 |
| 65 | MP0003724_increased_susceptibility_to | 1.03287828 |
| 66 | MP0002166_altered_tumor_susceptibility | 1.01445952 |
| 67 | MP0005645_abnormal_hypothalamus_physiol | 1.01230737 |
| 68 | MP0001849_ear_inflammation | 1.00263327 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 0.99041126 |
| 70 | MP0009764_decreased_sensitivity_to | 0.94773267 |
| 71 | MP0000733_abnormal_muscle_development | 0.90194578 |
| 72 | MP0000490_abnormal_crypts_of | 0.90143883 |
| 73 | MP0005310_abnormal_salivary_gland | 0.87656270 |
| 74 | MP0002009_preneoplasia | 0.87576822 |
| 75 | MP0001348_abnormal_lacrimal_gland | 0.86864091 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.84816464 |
| 77 | MP0000343_altered_response_to | 0.82985482 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.82877314 |
| 79 | MP0009384_cardiac_valve_regurgitation | 0.81275451 |
| 80 | MP0000681_abnormal_thyroid_gland | 0.80824676 |
| 81 | MP0000604_amyloidosis | 0.80229126 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.79280015 |
| 83 | MP0008961_abnormal_basal_metabolism | 0.77970382 |
| 84 | MP0003828_pulmonary_edema | 0.75826348 |
| 85 | MP0005621_abnormal_cell_physiology | 0.75431722 |
| 86 | MP0009115_abnormal_fat_cell | 0.74837202 |
| 87 | MP0008874_decreased_physiological_sensi | 0.72890276 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.71011266 |
| 89 | MP0002332_abnormal_exercise_endurance | 0.68558668 |
| 90 | MP0000313_abnormal_cell_death | 0.66547788 |
| 91 | MP0000751_myopathy | 0.65856092 |
| 92 | MP0003279_aneurysm | 0.65818174 |
| 93 | MP0001851_eye_inflammation | 0.65455652 |
| 94 | MP0000759_abnormal_skeletal_muscle | 0.65086028 |
| 95 | MP0000249_abnormal_blood_vessel | 0.65068336 |
| 96 | MP0002970_abnormal_white_adipose | 0.64940370 |
| 97 | MP0000678_abnormal_parathyroid_gland | 0.64103588 |
| 98 | MP0009931_abnormal_skin_appearance | 0.60264611 |
| 99 | MP0005334_abnormal_fat_pad | 0.60134492 |
| 100 | MP0003795_abnormal_bone_structure | 0.60080598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Panhypogammaglobulinemia (HP:0003139) | 3.98244921 |
| 2 | B lymphocytopenia (HP:0010976) | 3.67709928 |
| 3 | Dysostosis multiplex (HP:0000943) | 3.61496466 |
| 4 | Abnormality of B cell number (HP:0010975) | 3.41806507 |
| 5 | Granulocytopenia (HP:0001913) | 3.34865146 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 3.28427208 |
| 7 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.20455966 |
| 8 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.20455966 |
| 9 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.20455966 |
| 10 | Hypoplasia of the thymus (HP:0000778) | 3.13645046 |
| 11 | Mucopolysacchariduria (HP:0008155) | 3.08534459 |
| 12 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.08534459 |
| 13 | Abnormality of the fingertips (HP:0001211) | 3.06322602 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05583471 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05583471 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05583471 |
| 17 | Agammaglobulinemia (HP:0004432) | 3.01651345 |
| 18 | Asymmetric septal hypertrophy (HP:0001670) | 3.01250263 |
| 19 | Combined immunodeficiency (HP:0005387) | 2.96281651 |
| 20 | Cellulitis (HP:0100658) | 2.93791376 |
| 21 | Recurrent viral infections (HP:0004429) | 2.92479208 |
| 22 | Obstructive lung disease (HP:0006536) | 2.90152961 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.90152961 |
| 24 | Reticulocytosis (HP:0001923) | 2.89448412 |
| 25 | Loss of speech (HP:0002371) | 2.88188809 |
| 26 | Thrombocytosis (HP:0001894) | 2.86255192 |
| 27 | Meningitis (HP:0001287) | 2.82641819 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79151549 |
| 29 | Colitis (HP:0002583) | 2.78560716 |
| 30 | Hemorrhage of the eye (HP:0011885) | 2.74720930 |
| 31 | Hypertensive crisis (HP:0100735) | 2.74519533 |
| 32 | Broad face (HP:0000283) | 2.68106773 |
| 33 | Increased serum ferritin (HP:0003281) | 2.64981079 |
| 34 | Distal lower limb amyotrophy (HP:0008944) | 2.61962188 |
| 35 | Chest pain (HP:0100749) | 2.58677840 |
| 36 | Ragged-red muscle fibers (HP:0003200) | 2.58397904 |
| 37 | Recurrent fungal infections (HP:0002841) | 2.57249826 |
| 38 | Eosinophilia (HP:0001880) | 2.56529001 |
| 39 | Eczematoid dermatitis (HP:0000976) | 2.52483782 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.43250305 |
| 41 | Fatigue (HP:0012378) | 2.41821105 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 2.38726552 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.37112169 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.37050753 |
| 45 | Abnormality of eosinophils (HP:0001879) | 2.35571358 |
| 46 | Tubulointerstitial nephritis (HP:0001970) | 2.33895203 |
| 47 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.25677998 |
| 48 | Slow saccadic eye movements (HP:0000514) | 2.24142322 |
| 49 | Leukocytosis (HP:0001974) | 2.23852081 |
| 50 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21140587 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.15804370 |
| 52 | Polycythemia (HP:0001901) | 2.14848662 |
| 53 | Recurrent abscess formation (HP:0002722) | 2.13804072 |
| 54 | Sepsis (HP:0100806) | 2.13500892 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.13483092 |
| 56 | Epistaxis (HP:0000421) | 2.10893451 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.08146369 |
| 58 | Abnormality of reticulocytes (HP:0004312) | 2.07160020 |
| 59 | Abnormality of iron homeostasis (HP:0011031) | 2.06024296 |
| 60 | T lymphocytopenia (HP:0005403) | 2.02095507 |
| 61 | Rhabdomyolysis (HP:0003201) | 2.00096569 |
| 62 | Seborrheic dermatitis (HP:0001051) | 1.99059123 |
| 63 | Joint stiffness (HP:0001387) | 1.99012641 |
| 64 | Cervical subluxation (HP:0003308) | 1.98518453 |
| 65 | Verrucae (HP:0200043) | 1.97325837 |
| 66 | Papilloma (HP:0012740) | 1.97325837 |
| 67 | Hepatosplenomegaly (HP:0001433) | 1.96668647 |
| 68 | Vasculitis (HP:0002633) | 1.96001653 |
| 69 | Severe visual impairment (HP:0001141) | 1.95779044 |
| 70 | Exercise-induced myalgia (HP:0003738) | 1.95606437 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 1.95501713 |
| 72 | Cholecystitis (HP:0001082) | 1.95501713 |
| 73 | Peripheral hypomyelination (HP:0007182) | 1.92701782 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92452299 |
| 75 | Microvesicular hepatic steatosis (HP:0001414) | 1.91681757 |
| 76 | Easy fatigability (HP:0003388) | 1.91653820 |
| 77 | Spontaneous hematomas (HP:0007420) | 1.91019036 |
| 78 | Petechiae (HP:0000967) | 1.89320909 |
| 79 | Increased IgE level (HP:0003212) | 1.88260504 |
| 80 | Gastrointestinal stroma tumor (HP:0100723) | 1.86821554 |
| 81 | Hypergammaglobulinemia (HP:0010702) | 1.85769001 |
| 82 | Abnormality of the columella (HP:0009929) | 1.85729374 |
| 83 | Autoimmune thrombocytopenia (HP:0001973) | 1.85700161 |
| 84 | Ureteral stenosis (HP:0000071) | 1.83679729 |
| 85 | Personality changes (HP:0000751) | 1.83522028 |
| 86 | Increased cerebral lipofuscin (HP:0011813) | 1.83159729 |
| 87 | Myositis (HP:0100614) | 1.81172863 |
| 88 | Obstructive sleep apnea (HP:0002870) | 1.79910939 |
| 89 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79595774 |
| 90 | Ureteral obstruction (HP:0006000) | 1.79303083 |
| 91 | Acrocyanosis (HP:0001063) | 1.78485944 |
| 92 | Interstitial pulmonary disease (HP:0006530) | 1.78356700 |
| 93 | Abnormality of lateral ventricle (HP:0030047) | 1.78005162 |
| 94 | Restrictive lung disease (HP:0002091) | 1.77800435 |
| 95 | J-shaped sella turcica (HP:0002680) | 1.76756156 |
| 96 | Myopathic facies (HP:0002058) | 1.75798442 |
| 97 | Abnormality of the prostate (HP:0008775) | 1.75784292 |
| 98 | Thin bony cortex (HP:0002753) | 1.74332532 |
| 99 | Prolonged bleeding time (HP:0003010) | 1.71899666 |
| 100 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71204576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.29742556 |
| 2 | ERN1 | 3.15521077 |
| 3 | MAP4K1 | 3.14149344 |
| 4 | CDK12 | 2.78043193 |
| 5 | RIPK4 | 2.67795204 |
| 6 | MAP2K3 | 2.58508469 |
| 7 | TRIB3 | 2.56777412 |
| 8 | IRAK3 | 2.38358805 |
| 9 | SIK3 | 2.21686866 |
| 10 | SIK2 | 2.09051009 |
| 11 | EEF2K | 2.08860710 |
| 12 | MAP3K14 | 1.95490031 |
| 13 | ICK | 1.94877607 |
| 14 | MAP3K10 | 1.77124426 |
| 15 | BRD4 | 1.68039991 |
| 16 | PIK3CG | 1.67662056 |
| 17 | MAP3K13 | 1.67178246 |
| 18 | EPHB1 | 1.61457098 |
| 19 | SIK1 | 1.60814806 |
| 20 | TBK1 | 1.52547197 |
| 21 | IRAK4 | 1.51843164 |
| 22 | MATK | 1.49403077 |
| 23 | MAP3K6 | 1.46780888 |
| 24 | TYK2 | 1.38332081 |
| 25 | MAP3K11 | 1.37839843 |
| 26 | TAOK2 | 1.34034658 |
| 27 | SCYL2 | 1.32127289 |
| 28 | BLK | 1.29209143 |
| 29 | EPHA3 | 1.27340057 |
| 30 | BTK | 1.26382300 |
| 31 | MARK2 | 1.24614187 |
| 32 | MAP4K2 | 1.23834490 |
| 33 | ZAP70 | 1.18665870 |
| 34 | TAOK1 | 1.17307146 |
| 35 | TNK2 | 1.15341893 |
| 36 | NME2 | 1.09797001 |
| 37 | DDR2 | 1.09637852 |
| 38 | TESK2 | 1.08537002 |
| 39 | TESK1 | 1.08372426 |
| 40 | CDK4 | 1.08341896 |
| 41 | DYRK1B | 1.07621935 |
| 42 | PKN2 | 1.06424090 |
| 43 | JAK3 | 1.05114252 |
| 44 | MAP3K7 | 1.04358467 |
| 45 | IKBKB | 0.98643027 |
| 46 | CDC42BPA | 0.97931843 |
| 47 | SYK | 0.97599170 |
| 48 | FES | 0.88332384 |
| 49 | TTN | 0.88064935 |
| 50 | PDK1 | 0.85529503 |
| 51 | KIT | 0.83732920 |
| 52 | HCK | 0.83730411 |
| 53 | PDPK1 | 0.83627689 |
| 54 | BMPR2 | 0.82783310 |
| 55 | MTOR | 0.82516041 |
| 56 | SMG1 | 0.81941316 |
| 57 | CLK1 | 0.81764922 |
| 58 | MAP3K1 | 0.79272381 |
| 59 | PIM2 | 0.79076807 |
| 60 | GRK6 | 0.76248848 |
| 61 | PRKD2 | 0.75818867 |
| 62 | MAPK11 | 0.74639419 |
| 63 | BCKDK | 0.74507304 |
| 64 | MAP2K4 | 0.73978813 |
| 65 | CSF1R | 0.73701357 |
| 66 | TRIM28 | 0.72588315 |
| 67 | MAPK12 | 0.72375581 |
| 68 | RPS6KC1 | 0.70716282 |
| 69 | RPS6KL1 | 0.70716282 |
| 70 | MAPK15 | 0.70093401 |
| 71 | CDK6 | 0.68848728 |
| 72 | ITK | 0.68242622 |
| 73 | CAMK1D | 0.67646167 |
| 74 | HIPK2 | 0.66637342 |
| 75 | CHUK | 0.66421844 |
| 76 | RPS6KA2 | 0.65778461 |
| 77 | LYN | 0.65544330 |
| 78 | IKBKE | 0.62056096 |
| 79 | IRAK2 | 0.61290939 |
| 80 | JAK1 | 0.61132270 |
| 81 | LCK | 0.60872477 |
| 82 | FGFR4 | 0.60219859 |
| 83 | MAP3K3 | 0.59673133 |
| 84 | KSR2 | 0.59003291 |
| 85 | MAP2K7 | 0.58559773 |
| 86 | JAK2 | 0.58378969 |
| 87 | MAP3K5 | 0.57525607 |
| 88 | TXK | 0.57253274 |
| 89 | CSK | 0.55611132 |
| 90 | TEC | 0.54349661 |
| 91 | RET | 0.54191714 |
| 92 | PDGFRA | 0.53366633 |
| 93 | RPS6KA6 | 0.50735624 |
| 94 | MAPK7 | 0.50275425 |
| 95 | CDK9 | 0.48286588 |
| 96 | CAMK4 | 0.47135315 |
| 97 | MOS | 0.46934143 |
| 98 | NEK9 | 0.44659666 |
| 99 | FLT3 | 0.43376545 |
| 100 | DYRK3 | 0.41728771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.53113852 |
| 2 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.50733296 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.38560490 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.13287848 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.08301395 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01828001 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00651852 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.83226754 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82278995 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80136535 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.69949242 |
| 12 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67667396 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 1.66776589 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59319573 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58057848 |
| 16 | Hepatitis B_Homo sapiens_hsa05161 | 1.54249019 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52861957 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.47716692 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46936213 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43675410 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.41247385 |
| 22 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.39227530 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.39027405 |
| 24 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.38254458 |
| 25 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.37879644 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37740500 |
| 27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37643715 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37065272 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35455892 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34193335 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32601520 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.30930827 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30737477 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29938539 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.28399183 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.25939415 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24087770 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.22321743 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.21697009 |
| 40 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.19545821 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.14249911 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13122008 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12081408 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11816342 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.09258797 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08590377 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.05258862 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.04594258 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03778831 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01687122 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.01360019 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00675602 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.00110351 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 0.99375438 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.99233076 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98319874 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97276709 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96347048 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.95090404 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93887601 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93213980 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.91649603 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.91648705 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.91184644 |
| 65 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.88798021 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84478687 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81701918 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79071983 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78318899 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77755409 |
| 71 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77143635 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76824135 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.74785274 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74773923 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74214396 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.73833002 |
| 77 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73124689 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72736461 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71294333 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70078821 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.68562723 |
| 82 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68078962 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66768338 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.65434593 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.64820948 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63885448 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61737479 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.60272478 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56890612 |
| 90 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56463453 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.55301137 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.54538032 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54367251 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52449910 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52241851 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49838421 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49629476 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.48596804 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48361826 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47678605 |

